Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling
about
pATM and γH2AX are effective radiation biomarkers in assessing the radiosensitivity of 12C6+ in human tumor cells.Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.Silibinin attenuates radiation-induced intestinal fibrosis and reverses epithelial-to-mesenchymal transition.Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells.Flavonoids inhibit chronically exposed arsenic-induced proliferation and malignant transformation of HaCaT cells.Pituitary-Directed Therapies for Cushing's Disease.Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects
P2860
Q33604369-9D99F95C-D61F-464E-A382-49CF346F256FQ38734645-13079461-6702-4C29-A545-645B404FC998Q42378342-C95964C1-89E4-4282-A8D4-4196D1CF1D35Q46343477-96470ED9-1361-4364-916A-F277E5BF177DQ47835710-B6D5D9AF-4AC8-41AD-A698-F2CEACCC2A31Q54961209-DA81CB4C-843D-4F59-9C12-3274756664B6Q59127640-F2322E18-FBF9-41CE-8ACE-20827DF3E228
P2860
Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Silibinin Preferentially Radio ...... nhibiting DNA Repair Signaling
@ast
Silibinin Preferentially Radio ...... nhibiting DNA Repair Signaling
@en
type
label
Silibinin Preferentially Radio ...... nhibiting DNA Repair Signaling
@ast
Silibinin Preferentially Radio ...... nhibiting DNA Repair Signaling
@en
prefLabel
Silibinin Preferentially Radio ...... nhibiting DNA Repair Signaling
@ast
Silibinin Preferentially Radio ...... nhibiting DNA Repair Signaling
@en
P2093
P2860
P1476
Silibinin Preferentially Radio ...... nhibiting DNA Repair Signaling
@en
P2093
Anil K Jain
Dhanya K Nambiar
Gagan Deep
Paulraj Rajamani
Rajesh Agarwal
P2860
P304
P356
10.1158/1535-7163.MCT-15-0348
P577
2015-10-29T00:00:00Z